​

Kura Oncology (KURA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Kura Oncology Revenue Highlights

Latest Revenue (Y)

$67.48M

Latest Revenue (Q)

$20.87M

Main Segment (Y)

Collaboration Revenue

Kura Oncology Revenue by Period

Kura Oncology Revenue by Year

DateRevenueChange
2025-12-31$67.48M25.24%
2024-12-31$53.88M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31--

Kura Oncology generated $67.48M in revenue during NA 2025, up 25.24% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Kura Oncology Revenue by Quarter

DateRevenueChange
2026-06-30$20.87M14.28%
2026-03-31$18.27M5.36%
2025-12-31$17.34M-16.45%
2025-09-30$20.75M35.73%
2025-06-30$15.29M8.36%
2025-03-31$14.11M-73.82%
2024-12-31$53.88M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--100.00%
2018-12-31$2.44M100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30--

Kura Oncology generated $20.87M in revenue during Q2 2026, up 14.28% compared to the previous quarter, and up 147.96% compared to the same period a year ago.

Kura Oncology Revenue Breakdown

Kura Oncology Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25
Collaboration Revenue$65.35M
Product$2.13M

Kura Oncology's latest annual revenue breakdown by segment (product or service), as of Dec 25: Collaboration Revenue (96.84%), and Product (3.16%).

Quarterly Revenue by Product

Product/ServiceJun 26Mar 26Jun 25
Collaboration Revenue$11.75M$12.50M-
Product$9.12M$5.77M-
Operating Segments--$15.29M

Kura Oncology's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Collaboration Revenue (56.30%), and Product (43.70%).

Kura Oncology Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
HCMHUTCHMED (China)$838.00M$152.84M
RIGLRigel Pharmaceuticals$294.28M$78.70M
SNDXSyndax Pharmaceuticals$172.35M$72.79M
NRIXNurix Therapeutics$83.98M$673.06M
KURAKura Oncology$67.48M$20.87M
VSTMVerastem$30.91M$40.08M
BBOTBridgeBio Oncology Therapeutics--
SLSSELLAS Life Sciences Group--
CRDFCardiff Oncology--
TYRATyra Biosciences--
ORICORIC Pharmaceuticals--

KURA Revenue FAQ

What is Kura Oncology’s yearly revenue?

Kura Oncology's yearly revenue for 2025 was $67.48M, representing an increase of 25.24% compared to 2024. The company's yearly revenue for 2024 was $53.88M, representing an increase of 100.00% compared to 2023. KURA's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Kura Oncology’s quarterly revenue?

Kura Oncology's quarterly revenue for Q2 2026 was $20.87M, a 14.28% increase from the previous quarter (Q1 2026), and a 36.54% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $18.26M, a 5.36% increase from the previous quarter (Q4 2025), and a 29.47% increase year-over-year (Q1 2025). KURA's quarterly revenue for Q4 2025 was $17.34M, a -16.45% decrease from the previous quarter (Q3 2025), and a -67.83% decrease year-over-year (Q4 2024).

What is Kura Oncology’s revenue growth rate?

Kura Oncology's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.

What are Kura Oncology’s revenue streams?

Kura Oncology's revenue streams in c 25 are Collaboration Revenue, and Product. Collaboration Revenue generated $65.35M in revenue, accounting 96.84% of the company's total revenue Product generated $2.13M in revenue, accounting 3.16% of the company's total revenue

What is Kura Oncology’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Kura Oncology was Collaboration Revenue. This segment made a revenue of $65.35M, representing 96.84% of the company's total revenue.